Meton
Meton AI specializes in intelligent drug design, integrating in-house computational methods with organic synthesis capabilities for rapid candidate construction. Their interdisciplinary approach combines Physics, Chemistry, Biology, and Pharmacology with advanced in silico methods to accelerate drug discovery and optimize therapeutic development. They focus on neglected and emerging infectious diseases, including viruses like Zika, Dengue, SARS-CoV-2, SARS, and MERS. Meton AI utilizes machine learning and artificial intelligence for computer-aided drug design (CADD), enhancing efficacy and minimizing toxicity. Their process includes disease analysis, target selection, AI-driven CADD, organic synthesis, and experimental testing, aiming to bring new drugs to market efficiently. The company was founded in 2019 as a spin-off of Cavasotto Lab.
Meton
Meton AI specializes in intelligent drug design, integrating in-house computational methods with organic synthesis capabilities for rapid candidate construction. Their interdisciplinary approach combines Physics, Chemistry, Biology, and Pharmacology with advanced in silico methods to accelerate drug discovery and optimize therapeutic development. They focus on neglected and emerging infectious diseases, including viruses like Zika, Dengue, SARS-CoV-2, SARS, and MERS. Meton AI utilizes machine learning and artificial intelligence for computer-aided drug design (CADD), enhancing efficacy and minimizing toxicity. Their process includes disease analysis, target selection, AI-driven CADD, organic synthesis, and experimental testing, aiming to bring new drugs to market efficiently. The company was founded in 2019 as a spin-off of Cavasotto Lab.